1. Home
  2. MEGL vs LIXT Comparison

MEGL vs LIXT Comparison

Compare MEGL & LIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MEGL
  • LIXT
  • Stock Information
  • Founded
  • MEGL 2016
  • LIXT 2005
  • Country
  • MEGL Hong Kong
  • LIXT United States
  • Employees
  • MEGL N/A
  • LIXT N/A
  • Industry
  • MEGL Finance: Consumer Services
  • LIXT Biotechnology: Pharmaceutical Preparations
  • Sector
  • MEGL Finance
  • LIXT Health Care
  • Exchange
  • MEGL Nasdaq
  • LIXT Nasdaq
  • Market Cap
  • MEGL 4.8M
  • LIXT 4.1M
  • IPO Year
  • MEGL 2022
  • LIXT N/A
  • Fundamental
  • Price
  • MEGL $1.27
  • LIXT $1.26
  • Analyst Decision
  • MEGL
  • LIXT
  • Analyst Count
  • MEGL 0
  • LIXT 0
  • Target Price
  • MEGL N/A
  • LIXT N/A
  • AVG Volume (30 Days)
  • MEGL 24.6K
  • LIXT 8.5K
  • Earning Date
  • MEGL 05-06-2025
  • LIXT 05-08-2025
  • Dividend Yield
  • MEGL N/A
  • LIXT N/A
  • EPS Growth
  • MEGL N/A
  • LIXT N/A
  • EPS
  • MEGL N/A
  • LIXT N/A
  • Revenue
  • MEGL $1,645,862.00
  • LIXT N/A
  • Revenue This Year
  • MEGL N/A
  • LIXT N/A
  • Revenue Next Year
  • MEGL N/A
  • LIXT N/A
  • P/E Ratio
  • MEGL N/A
  • LIXT N/A
  • Revenue Growth
  • MEGL N/A
  • LIXT N/A
  • 52 Week Low
  • MEGL $0.41
  • LIXT $1.02
  • 52 Week High
  • MEGL $3.06
  • LIXT $3.50
  • Technical
  • Relative Strength Index (RSI)
  • MEGL 49.81
  • LIXT 50.56
  • Support Level
  • MEGL $1.12
  • LIXT $1.10
  • Resistance Level
  • MEGL $1.24
  • LIXT $1.24
  • Average True Range (ATR)
  • MEGL 0.13
  • LIXT 0.13
  • MACD
  • MEGL -0.00
  • LIXT 0.02
  • Stochastic Oscillator
  • MEGL 59.52
  • LIXT 39.49

About MEGL Magic Empire Global Limited

Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

Share on Social Networks: